Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
GeneDx Holdings Corp. - Class A Common Stock
(NQ:
WGS
)
131.76
-5.71 (-4.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,343,587
Open
136.54
Bid (Size)
124.50 (1)
Ask (Size)
138.88 (1)
Prev. Close
137.47
Today's Range
129.78 - 142.93
52wk Range
55.17 - 146.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
GeneDx (WGS) Q3 2025 Earnings Call Transcript
October 28, 2025
GeneDx (WGS) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher
October 28, 2025
GeneDx Q3 2025 earnings crush estimates with 52% revenue growth. Strong exome/genome test demand and raised 2025 guidance fuel investor optimism.
Via
Chartmill
Topics
Earnings
Performance
YTD
+65.5%
+65.5%
1 Month
+15.6%
+15.6%
3 Month
+43.6%
+43.6%
6 Month
+12.6%
+12.6%
1 Year
+135.0%
+135.0%
More News
Read More
Earnings Scheduled For October 28, 2025
October 28, 2025
Via
Benzinga
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
October 28, 2025
From
GeneDx
Via
Business Wire
GeneDx Hldgs's Earnings: A Preview
October 27, 2025
Via
Benzinga
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
October 24, 2025
From
Halper Sadeh LLC
Via
Business Wire
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
October 22, 2025
From
GeneDx
Via
Business Wire
4 Analysts Assess GeneDx Holdings: What You Need To Know
October 20, 2025
Via
Benzinga
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
October 20, 2025
From
GeneDx
Via
Business Wire
This WillScot Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
October 20, 2025
Via
Benzinga
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
October 14, 2025
From
GeneDx
Via
Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Presents a High-Growth Momentum and Technical Breakout Case
October 14, 2025
Via
Chartmill
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
October 13, 2025
From
GeneDx
Via
Business Wire
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
October 09, 2025
From
GeneDx
Via
Business Wire
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
October 08, 2025
From
GeneDx
Via
Business Wire
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
October 07, 2025
From
GeneDx
Via
Business Wire
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
October 01, 2025
From
GeneDx
Via
Business Wire
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
September 30, 2025
From
GeneDx
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2025
Via
Benzinga
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
September 25, 2025
From
GeneDx
Via
Business Wire
GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Positive Technical Setup
September 22, 2025
Via
Chartmill
GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
September 18, 2025
From
GeneDx
Via
Business Wire
Assessing GeneDx Holdings: Insights From 5 Financial Analysts
September 11, 2025
Via
Benzinga
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
September 04, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating GeneDx Holdings Corp. on Behalf of Stockholders and Encourages Investors to Contact the Firm
September 04, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Frequently Asked Questions
Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 131.76
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 10/29/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
